2I
28bio, Inc.
SEC filingBiotechnology · Metairie, LA
Amount raised$6.5Msold at filing
Total offering$7M$475K still open
Investors in the raise8count reported to the SEC
FiledJan 27, 2026first sale May 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Miklos KoborDirector
Michael KatzDirector
Dale PfostDirector
Alif SalehExecutive Officer, Director
David WeinerDirector
Executive officers, directors and promoters as listed on the Form D.